Some types of PD-1 and PD-L1 inhibitors are available as subcutaneous injections that a cancer care professional injects into fat under the skin. These subcutaneous medications include ...

The extended injection time for subcutaneous daratumumab in those with myeloma can serve as an opportunity for oncology nurses to check in with patients.